Metabolic features of cancer cells in NRF2 addiction status

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works

Comprehensive genomic characterization of squamous cell lung cancers

The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994 · see citing works

The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis

Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968 · see citing works

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789 · see citing works

Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · see citing works

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336 · see citing works

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

Cancer Genome Atlas Research Network, Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., et al. (2016) · Nature Genetics · doi:10.1038/ng.3564 · Cited by 1,200 · see citing works

Serine and one-carbon metabolism in cancer

Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992 · see citing works

NRF2 regulates serine biosynthesis in non–small cell lung cancer

DeNicola, G. M., Chen, P.-H., Mullarky, E., Sudderth, J., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J. M., Huffman, K. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3421 · Cited by 747 · see citing works

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733 · see citing works

Cancer related mutations in <i>NRF2</i> impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728 · see citing works

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

Romero, R., Sayin, V. I., Davidson, S. M., Bauer, M. R., Singh, S. X., LeBoeuf, S. E., Karakousi, T. R., Ellis, D. C., Bhutkar, A., Sánchez-Rivera, F. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4407 · Cited by 652 · see citing works

Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1

Lignitto, L., LeBoeuf, S. E., Homer, H., Jiang, S., Askenazi, M., Karakousi, T. R., Pass, H. I., Bhutkar, A. J., Tsirigos, A., Ueberheide, B., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.003 · Cited by 573 · see citing works

Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics

Akaike, T., Ida, T., Wei, F., Nishida, M., Kumagai, Y., Alam, M. M., Ihara, H., Sawa, T., Matsunaga, T., Kasamatsu, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01311-y · Cited by 546 · see citing works

Effects of Co-occurring Genomic Alterations on Outcomes in Patients with <i>KRAS</i> -Mutant Non–Small Cell Lung Cancer

Arbour, K. C., Jordan, E., Kim, H. R., Dienstag, J., Yu, H. A., Sanchez-Vega, F., Lito, P., Berger, M., Solit, D. B., Hellmann, M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1841 · Cited by 466 · see citing works

Serine Metabolism Supports Macrophage IL-1β Production

Rodriguez, A. E., Ducker, G. S., Billingham, L. K., Martinez, C. A., Mainolfi, N., Suri, V., Friedman, A. A., Manfredi, M. G., Weinberg, S. E., Rabinowitz, J. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.014 · Cited by 343 · see citing works

The Scission Of The Sulfur-Sulfur Bond

Parker, A. J., & Kharasch, N. (1959) · Chemical Reviews · doi:10.1021/cr50028a003 · Cited by 329 · see citing works

Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers

Mukhopadhyay, S., Goswami, D., Adiseshaiah, P. P., Burgan, W., Yi, M., Guerin, T. M., Kozlov, S. V., Nissley, D. V., & McCormick, F. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1363 · Cited by 279 · see citing works

NRF2 addiction in cancer cells

Kitamura, H., & Motohashi, H. (2018) · Cancer Science · doi:10.1111/cas.13537 · Cited by 275 · see citing works

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer

Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231 · see citing works

NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer

Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T., et al. (2011) · Neoplasia · doi:10.1593/neo.11750 · Cited by 224 · see citing works

Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition

Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Οhyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 209 · see citing works

Accumulation of p62/ SQSTM 1 is associated with poor prognosis in patients with lung adenocarcinoma

Inoue, D., Suzuki, T., Mitsuishi, Y., Miki, Y., Suzuki, S., Sugawara, S., Watanabe, M., Sakurada, A., Endo, C., Uruno, A., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02216.x · Cited by 204 · see citing works

Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung

Satoh, H., Moriguchi, T., Taguchi, K., Takai, J., Maher, J. M., Suzuki, T., Winnard, P. T., Raman, V., Ebina, M., Nukiwa, T., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq105 · Cited by 197 · see citing works

Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids

LeBoeuf, S. E., Wu, W. L., Karakousi, T. R., Karadal, B., Jackson, S. R., Davidson, S. M., Wong, K.-K., Koralov, S. B., Sayin, V. I., & Papagiannakopoulos, T. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.012 · Cited by 150 · see citing works

Sustained Activation of Nuclear Erythroid 2-Related Factor 2/Antioxidant Response Element Signaling Promotes Reductive Stress in the Human Mutant Protein Aggregation Cardiomyopathy in Mice

Rajasekaran, N. S., Varadharaj, S., Khanderao, G. D., Davidson, C. J., Kannan, S., Firpo, M. A., Zweier, J. L., & Benjamin, I. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3587 · Cited by 140 · see citing works

Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer

Kang, Y. P., Torrente, L., Falzone, A., Elkins, C. M., Liu, M., Asara, J. M., Dibble, C. C., & DeNicola, G. M. (2019) · eLife · doi:10.7554/elife.45572 · Cited by 126 · see citing works

Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non–Small Cell Lung Cancer

Jeong, Y., Hellyer, J. A., Stehr, H., Hoang, N. T., Niu, X., Das, M. S., Padda, S. K., Ramchandran, K. J., Neal, J. W., Wakelee, H. A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1237 · Cited by 125 · see citing works

Chronic activation of JNK JAK/STAT and oxidative stress signalling causes the loser cell status

Kuciński, I., Dinan, M., Kolahgar, G., & Piddini, E. (2017) · Nature Communications · doi:10.1038/s41467-017-00145-y · Cited by 115 · see citing works

Amino acid management in cancer

Tsun, Z.-Y., & Possemato, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.002 · Cited by 113 · see citing works

Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers

Taguchi, K., Hirano, I., Itoh, T., Tanaka, M., Miyajima, A., Suzuki, A., Motohashi, H., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01384-13 · Cited by 98 · see citing works

Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy

Kannan, S., Muthusamy, V. R., Whitehead, K. J., Wang, L., Gomes, A. V., Litwin, S. E., Kensler, T. W., Abel, E. D., Hoidal, J. R., & Rajasekaran, N. S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt150 · Cited by 96 · see citing works

Myeloid Lineage–Specific Deletion of Antioxidant System Enhances Tumor Metastasis

Hiramoto, K., Satoh, H., Suzuki, T., Moriguchi, T., Pi, J., Shimosegawa, T., & Yamamoto, M. P. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0094 · Cited by 94 · see citing works

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

Onodera, Y., Motohashi, H., Takagi, K., Miki, Y., Shibahara, Y., Watanabe, M., Ishida, T., Hirakawa, H., Sasano, H., Yamamoto, M., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0234 · Cited by 81 · see citing works

Correlation of Nrf2, HO-1, and MRP3 in Gallbladder Cancer and Their Relationships to Clinicopathologic Features and Survival

Wang, J., Zhang, M., Zhang, L., Cai, H., Zhou, S., Zhang, J., & Wang, Y. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.05.058 · Cited by 75 · see citing works

NRF2 Activation Impairs Quiescence and Bone Marrow Reconstitution Capacity of Hematopoietic Stem Cells

Murakami, S., Suzuki, T., Harigae, H., Roméo, P., Yamamoto, M. P., & Motohashi, H. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00086-17 · Cited by 71 · see citing works

Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer

Martínez, V. D., Vucic, E. A., Thu, K. L., Pikor, L. A., Lam, S. C., & Lam, W. L. (2014) · Head & Neck · doi:10.1002/hed.23663 · Cited by 70 · see citing works

Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation

Tsakiri, E. N., Gumeni, S., Iliaki, K. K., Benaki, D. C., Vougas, K. N., Sykiotis, G. P., Gorgoulis, V. G., Mikros, E., Scorrano, L., & Trougakos, I. P. (2018) · Aging Cell · doi:10.1111/acel.12845 · Cited by 70 · see citing works

The occurrence of bis-(2-amino-2-carboxyethyl) trisulphide in hydrolysates of wool and other proteins

Fletcher, J. C., & Robson, A. (1963) · Biochemical Journal · doi:10.1042/bj0870553 · Cited by 69 · see citing works

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients

Kanamori, M., Higa, T., Sonoda, Y., Murakami, S., Dodo, M., Kitamura, H., Taguchi, K., Shibata, T., Watanabe, M., Suzuki, H., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou282 · Cited by 57 · see citing works

IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model

Kitamura, H., Onodera, Y., Murakami, S., Suzuki, T., & Motohashi, H. (2017) · Oncogene · doi:10.1038/onc.2017.236 · Cited by 54 · see citing works

Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites

Saigusa, D., Motoike, I. N., Saito, S., Zorzi, M., Aoki, Y., Kitamura, H., Suzuki, M., Katsuoka, F., Ishii, H., Kinoshita, K., et al. (2019) · Cancer Science · doi:10.1111/cas.14278 · Cited by 41 · see citing works

Concomitant Nrf2- and ATF4-Activation by Carnosic Acid Cooperatively Induces Expression of Cytoprotective Genes

Mimura, J., Inose-Maruyama, A., Taniuchi, S., Kosaka, K., Yoshida, H., Yamazaki, H., Kasai, S., Harada, N., Kaufman, R. J., Oyadomari, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071706 · Cited by 39 · see citing works

Persulfide properties of thiocystine and related trisulfides

Abdolrasulnia, R., & Wood, J. L. (1980) · Bioorganic Chemistry · doi:10.1016/0045-2068(80)90026-7 · Cited by 20 · see citing works

Glutamine reliance in cell metabolism

Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental &amp; Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works

Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond

Esteras, N., & Abramov, A. Y. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.013 · Cited by 214 · see citing works

Pterostilbene in Cancer Therapy

Obrador, E., Palmer, R. S., Jihad-Jebbar, A., López‐Blanch, R., Dellinger, T. H., Dellinger, R. W., & Estrela, J. M. (2021) · Antioxidants · doi:10.3390/antiox10030492 · Cited by 103 · see citing works

The KEAP1-NRF2 System in Healthy Aging and Longevity

Matsumaru, D., & Motohashi, H. (2021) · Antioxidants · doi:10.3390/antiox10121929 · Cited by 99 · see citing works

Lipid peroxidation: Reactive carbonyl species, protein/DNA adducts, and signaling switches in oxidative stress and cancer

Moldogazieva, N. T., Zavadskiy, S. P., Astakhov, D. V., & Terentiev, A. A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149167 · Cited by 84 · see citing works

Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer

Dekhne, A. S., Hou, Z., Gangjee, A., & Matherly, L. H. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0423 · Cited by 80 · see citing works

Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment

Kumar, H., Kumar, R. M., Bhattacharjee, D., Somanna, P., & Jain, V. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.720076 · Cited by 75 · see citing works

Contribution of NRF2 to sulfur metabolism and mitochondrial activity

Alam, M. M., Kishino, A., Sung, E., Sekine, H., Abe, T., Murakami, S., Akaike, T., & Motohashi, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102624 · Cited by 72 · see citing works

Deregulated transcription factors in cancer cell metabolisms and reprogramming

Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 74 · see citing works

Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment

Endo, H., Owada, S., Inagaki, Y., Shida, Y., & Tatemichi, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101643 · Cited by 63 · see citing works

Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer

Sekine, H., & Motohashi, H. (2021) · Cancers · doi:10.3390/cancers13030541 · Cited by 51 · see citing works

Nuclear factor erythroid 2–related factor 2 and β‐Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications

Tao, J., Krutsenko, Y., Moghe, A., Singh, S., Poddar, M., Bell, A., Oertel, M., Singhi, A. D., Geller, D., Chen, X., et al. (2021) · Hepatology · doi:10.1002/hep.31730 · Cited by 54 · see citing works

PPIA dictates NRF2 stability to promote lung cancer progression

Lü, W., Cui, J., Wang, W., Hu, Q., Xue, Y., Liu, X., Gong, T., Lu, Y., Ma, H., Yang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48364-4 · Cited by 52 · see citing works

Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 42 · see citing works

Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype

Hallis, S. P., Kim, J. M., & Kwak, M. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2196 · Cited by 37 · see citing works

Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response

Gall‐Tros̆elj, K., Tomljanović, M., Jaganjac, M., Glavan, T. M., Gašparović, A. Č., Milković, L., Šunjić, S. B., Buttari, B., Profumo, E., Saha, S., et al. (2022) · Molecules · doi:10.3390/molecules27051468 · Cited by 38 · see citing works

The role of NRF2 transcription factor in inflammatory skin diseases

Salman, S., Paulet, V., Hardonnière, K., & Kerdine‐Römer, S. (2025) · BioFactors · doi:10.1002/biof.70013 · Cited by 37 · see citing works

CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells

Okazaki, K., Anzawa, H., Katsuoka, F., Kinoshita, K., Sekine, H., & Motohashi, H. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac013 · Cited by 33 · see citing works

Design and synthesis of isothiocyanate‐containing hybrid androgen receptor (AR) antagonist to downregulate AR and induce ferroptosis in GSH–Deficient prostate cancer cells

Qin, Z., Ou, S., Xu, L., Sorensen, K., Zhang, Y., Hu, D., Yang, Z., Hu, W., Chen, F., & Prins, G. S. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13826 · Cited by 32 · see citing works

Heterogeneity of the cancer cell line metabolic landscape

Shorthouse, D., Bradley, J., Critchlow, S. E., Bendtsen, C., & Hall, B. A. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211006 · Cited by 24 · see citing works

Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2

Samec, M., Mazuráková, A., Lučanský, V., Koklesová, L., Péčová, R., Péč, M. J., Golubnitschaja, O., AL-Ishaq, R. K., Čaprnda, M., Gašpar, Ľ., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175655 · Cited by 22 · see citing works

Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer

Wang, P., Long, F., Lin, H., Wang, S., & Wang, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7848811 · Cited by 21 · see citing works

Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review

Moubarak, M. M., Zottola, A. C. P., Larrieu, C. M., Cuvellier, S., Daubon, T., & Martin, O. C. B. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad160 · Cited by 19 · see citing works

Genetic, metabolic and immunological features of cancers with NRF2 addiction

Kitamura, H., Takeda, H., & Motohashi, H. (2022) · FEBS Letters · doi:10.1002/1873-3468.14458 · Cited by 15 · see citing works

The GSH Colorimetric Method as Measurement of Antioxidant Status in Serum and Rodent Tissues

Vuolo, M. M., da Silva-Maia, J. K., & Batista, Â. G. (2022) · Methods and protocols in food science · doi:10.1007/978-1-0716-2345-9_12 · Cited by 13 · see citing works

Biophysical Reviews’ national biophysical society partnership program

Hall, D. R. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00693-6 · Cited by 12 · see citing works

Carbon Monoxide‐Releasing Molecule‐3 Suppresses the Malignant Biological Behavior of Tongue Squamous Cell Carcinoma via Regulating Keap1/Nrf2/HO‐1 Signaling Pathway

Dai, Y., Chen, H., Pan, Y., & Song, H. (2022) · BioMed Research International · doi:10.1155/2022/9418332 · Cited by 10 · see citing works

NRF2 and Primary Cilia: An Emerging Partnership

Martín-Hurtado, A., Lastres‐Becker, I., Cuadrado, A., & García-Gonzalo, F. R. (2020) · Antioxidants · doi:10.3390/antiox9060475 · Cited by 10 · see citing works

How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy

Tang, Y.-C., Chuang, Y., Chang, H.-H., Juang, S., Yen, G., Chang, J.-Y., & Kuo, C. (2023) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3463 · Cited by 9 · see citing works

The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes

Moghadam, D., Zarei, R., Rostami, A., Samare‐Najaf, M., Ghojoghi, R., Savardashtaki, A., Jafarinia, M., Vakili, S., & Irajie, C. (2024) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206317999240708062744 · Cited by 9 · see citing works

Induction of Cardiac Pathology: Endogenous versus Exogenous Nrf2 Upregulation

Mathis, B. J., Kato, H., & Hiramatsu, Y. (2022) · Cells · doi:10.3390/cells11233855 · Cited by 9 · see citing works

Mechanistic Analysis of an Extracellular Signal–Regulated Kinase 2–Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress

Martinez, R., Huang, W., Samadani, R., Mackowiak, B., Centola, G. A., Chen, L., Conlon, I. L., Hom, K., Kane, M. A., Fletcher, S., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000266 · Cited by 9 · see citing works

64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity

Nachankar, A., Oike, T., Hanaoka, H., Kanai, A., Sato, H., Yoshida, Y., Obinata, H., Sakai, M., Osu, N., Hirota, Y., et al. (2021) · Cancers · doi:10.3390/cancers13246159 · Cited by 9 · see citing works

Biophysical Reviews: 2020—looking back, going forward

Hall, D. R. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00777-3 · Cited by 9 · see citing works

Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis

Lin, Y., Ku, C., Wuputra, K., Wu, D., & Yokoyama, K. K. (2024) · Cells · doi:10.3390/cells13191648 · Cited by 8 · see citing works

NRF2 activation in cancer and overview of NRF2 small molecule inhibitors

Ngo, H. H., Yu, B.-Y., Lee, J., Kim, H. W., & Keum, Y. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01557-x · Cited by 8 · see citing works

A clinical decision framework for redox-adapted, EMT-high cancers: From ferroptosis resistance to precision therapeutic stratification

Park, M. N., Kim, H. S., Park, S., Syahputra, R. A., Delfino, D. V., Ko, S., & Kim, B. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104111 · Cited by 9 · see citing works

Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease

Dasgupta, D., Tripathi, A., Griffard-Smith, R., Yellapu, N. K., Dhorajiya, P., & Pyaram, K. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf117 · Cited by 7 · see citing works

Turning off the ferroptosis switch: ACAA1-Driven PI3K/AKT/Nrf2 signaling as a novel driver of endometrial cancer progression

Lang, T., Xiao, P., Hua, S., Liang, X., & Yang, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.09.054 · Cited by 7 · see citing works

The methylome of buccal epithelial cells is influenced by age, sex, and physiological properties

Protti, G., Rubbi, L., Gören, T., Sabırlı, R., Civlan, S., Kurt, Ö., Türkçüer, İ., Köseler, A., & Pellegrini, M. A. (2023) · Physiological Genomics · doi:10.1152/physiolgenomics.00063.2023 · Cited by 6 · see citing works

Pyrimethamine and a potent analog inhibit NRF2 by suppressing one-carbon metabolism

Chembo, J., Bowman, B. M., LaPak, K. M., Wilkerson, E., Wamsley, N. T., Paiboonrungruang, C., Cho, K., Medcalf, M. R., Wang, H., Patti, G. J., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110659 · Cited by 5 · see citing works

A Review Unveiling the Ferroptosis-Regulated Cell Signalling Pathways in Breast Cancer to Elucidate Potent Targets for Cancer Management

Pandey, P., Pandey, S., Ramniwas, S., Ballal, S., Kumar, S., Bhat, M., Sharma, S., Kumar, M., & Khan, F. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128343266241230045019 · Cited by 4 · see citing works

Pyrimethamine and a potent analogue WCDD115 inhibit NRF2 by suppressing DHFR and one-carbon metabolismPreprint

Chembo, J., Bowman, B. M., LaPak, K. M., Wilkerson, E., Paiboonrungruang, C., Cho, K., Medcalf, M. R., Patti, G. J., Dolle, R. E., Chen, X. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.637433 · Cited by 4 · see citing works

Transcriptional and biochemical changes in mouse liver following exposure to a metal/drug cocktail. Attenuating effect of a selenium-enriched diet

Huertas-Abril, P. V., Prieto‐Álamo, M., Jurado, J., Pérez, J., Molina-Hernández, V., García‐Barrera, T., & Abril, N. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114845 · Cited by 3 · see citing works

Review on Curcumin Compounds in Turmeric Plants for the Treatment of COVID-19

Irfandi, R., Ilham, M. A., Erwing, E., Ruslang, Arafah, M., Rompegading, A. B., Putri, S. E., Sartika, S. D., Fauziah, S., Agustina, A. S., et al. (2022) · International Journal of Design & Nature and Ecodynamics · doi:10.18280/ijdne.170618 · Cited by 2 · see citing works

GCs-beta and B-arrestins Regulate Nrf2 via NR4As Productive Pathway Mediated by B-adrenergic for Anti-inflammation and Adopting Myocardial and Immune Functions

Tantawi, A. M. E. (2023) · Japan Journal of Clinical & Medical Research · doi:10.47363/jjcmr/2023(3)151 · Cited by 2 · see citing works

Glucocorticoid-Beta Regulate B-Adrenergic and Nrf2 via NR4As Productive Pathway For Activating Anti-Inflammation Include Antioxidant Functions and Myocardial Immune Functions

Biomedical Molecular Studies & Cancer Diseases. Home Adress: Canada, T., & Tantawi, A. M. E. (2023) · Medicine and Clinical Science · doi:10.33425/2690-5191.1081 · Cited by 2 · see citing works

Study of the Role of NRF2 in the Progression and Metabolic Adaptation of Glioblastoma

Moubarak, M. M. (2024) · doi:10.70675/c7f50cd9za643z437dza037z13798faf9515 · Cited by 2 · see citing works

Flavonoids Attentuate Cancer Metabolism by Modulating Redox State, lipid metabolism, and use of amino acids or ketone bodiesPreprint

Samec, M., Mazuráková, A., Lučanský, V., Koklesová, L., Péčová, R., Péč, M. J., Golubnitschaja, O., AL-Ishaq, R. K., Čaprnda, M., Gašpar, Ľ., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2273746/v1

Characterization of murine isogenic normal and NRF2-KO colon epithelial cells to explore the food contaminants toxicity and oxidative stress involvement.Preprint

Dupuy, J., Fouché, E., Noirot, C., Martin, P., Buisson, C., Guéraud, F., Pierre, F. H. F., & Héliès‐Toussaint, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2385028/v1

A dual model of normal vs isogenic Nrf2-depleted murine epithelial cells to explore oxidative stress involvement

Dupuy, J., Fouché, E., Noirot, C., Martin, P., Buisson, C., Guéraud, F., Pierre, F. H. F., & Héliès‐Toussaint, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-60938-2

Regnase-1 Promotes Tumor-Initiating Activity in Non-Small Cell Lung CancerPreprint

Okazaki, K., Kawaguchi, M., Murakami, S., Takeda, H., Sekine, H., Takeuchi, O., & Motohashi, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663650

Regnase-1 Promotes Tumour-Initiating Activity in Non-Small Cell Lung Cancer

Okazaki, K., Kawaguchi, M., Murakami, S., Takeda, H., Sekine, H., Takeuchi, O., & Motohashi, H. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf061

Combined administration of synthetic monophenol TS-13 with doxorubicin enhances the antimitotic effect and mitigates adverse effects of the cytostatic in tumor growth model

Евгеньевна, С. А., Валерьевна, Х. М., Петрова, Е. С., Romakh, L. P., Кандалинцева, Н. В., & Брониславовна, М. Е. (2026) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20250619

Molecular mechanisms and targeted therapeutic strategies for glycolytic reprogramming in osteosarcoma

Ni, X., Xia, P., Liang, M., Zhang, L. Q., Chen, J., He, Z., Huang, H., Feng, J., Niu, X., & Pu, F. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102111

Enhancing Tumour Radiosensitivity by Targeting Nrf2 Antioxidant System

Golyshev, G., Tikunova, K. V., Deeni, Y., & Goltsov, A. N. (2026) · Medical Radiology and radiation safety · doi:10.33266/1024-6177-2026-71-5-20-32

The tumor suppressive role of KEAP1: Underlying mechanisms and therapeutic implications

Zhang, Z., Jin, X., Chen, J., Liu, K., & Dai, X. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168260

Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer

Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231 · see citing works

Bright and dark sides of KEAP1-NRF2 system in carcinogenesis

Motohashi, H., Ida, T., Alam, M. M., Kitamura, H., & Akaike, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.078

Genetic, metabolic and immunological features of cancers with NRF2 addiction

Kitamura, H., Takeda, H., & Motohashi, H. (2022) · FEBS Letters · doi:10.1002/1873-3468.14458 · Cited by 15 · see citing works

NRF2 addiction in cancer cells

Kitamura, H., & Motohashi, H. (2018) · Cancer Science · doi:10.1111/cas.13537 · Cited by 275 · see citing works

The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism

Song, M.-Y., Lee, D.-Y., Chun, K., & Kim, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094376 · Cited by 166 · see citing works